Clinical trials

Eligible studies based on your profile

Open trials

  • Type 2 diabetes — once-weekly GLP-1

    T-2401 · Bengaluru

    Phase 3
    Compensation: ₹15,000

  • Hypertension — novel ARB combination

    T-2402 · Mumbai

    Phase 2
    Compensation: ₹12,000

  • Migraine — preventive monoclonal

    T-2403 · Pan-India

    Phase 3
    Compensation: ₹18,000